“Commentary on ‘Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial’”, Bleeding Thromb Vascul Biol, vol. 3, no. 2, Jun. 2024, doi: 10.4081/btvb.2024.141.